Literature DB >> 17332413

Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity.

Benjamin R Tenoever1, Sze-Ling Ng, Mark A Chua, Sarah M McWhirter, Adolfo García-Sastre, Tom Maniatis.   

Abstract

IKKepsilon is an IKK (inhibitor of nuclear factor kappaBkinase)-related kinase implicated in virus induction of interferon-beta (IFNbeta). We report that, although mice lacking IKKepsilon produce normal amounts of IFNbeta, they are hypersusceptible to viral infection because of a defect in the IFN signaling pathway. Specifically, a subset of type I IFN-stimulated genes are not activated in the absence of IKKepsilon because the interferon-stimulated gene factor 3 complex (ISGF3) does not bind to promoter elements of the affected genes. We demonstrate that IKKepsilon is activated by IFNbeta and that IKKepsilon directly phosphorylates signal transducer and activator of transcription 1 (STAT1), a component of ISGF3. We conclude that IKKepsilon plays a critical role in the IFN-inducible antiviral transcriptional response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17332413     DOI: 10.1126/science.1136567

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  183 in total

Review 1.  The role of nuclear factor κB in the interferon response.

Authors:  Lawrence M Pfeffer
Journal:  J Interferon Cytokine Res       Date:  2011-06-01       Impact factor: 2.607

2.  Role of interferon regulatory factor 7 in serum-transfer arthritis: regulation of interferon-β production.

Authors:  Susan E Sweeney; Maripat Corr; Trevor B Kimbler
Journal:  Arthritis Rheum       Date:  2011-11-10

3.  Targeting an IKBKE cytokine network impairs triple-negative breast cancer growth.

Authors:  Thanh U Barbie; Gabriela Alexe; Amir R Aref; Shunqiang Li; Zehua Zhu; Xiuli Zhang; Yu Imamura; Tran C Thai; Ying Huang; Michaela Bowden; John Herndon; Travis J Cohoon; Timothy Fleming; Pablo Tamayo; Jill P Mesirov; Shuji Ogino; Kwok-Kin Wong; Matthew J Ellis; William C Hahn; David A Barbie; William E Gillanders
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 4.  PI3K-independent AKT activation in cancers: a treasure trove for novel therapeutics.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  J Cell Physiol       Date:  2012-09       Impact factor: 6.384

5.  Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.

Authors:  Joanna A Pulit-Penaloza; Svetlana V Scherbik; Margo A Brinton
Journal:  Virology       Date:  2012-02-03       Impact factor: 3.616

6.  Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses.

Authors:  Ryan A Langlois; Andrew Varble; Mark A Chua; Adolfo García-Sastre; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

7.  The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.

Authors:  Suhu Liu; Anna E Marneth; Gabriela Alexe; Sarah R Walker; Helen I Gandler; Darwin Q Ye; Katherine Labella; Radhika Mathur; Patricia A Toniolo; Michelle Tillgren; Prafulla C Gokhale; David Barbie; Ann Mullally; Kimberly Stegmaier; David A Frank
Journal:  Blood Adv       Date:  2018-12-11

Review 8.  West Nile virus infection and immunity.

Authors:  Mehul S Suthar; Michael S Diamond; Michael Gale
Journal:  Nat Rev Microbiol       Date:  2013-02       Impact factor: 60.633

9.  IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex.

Authors:  Alicia Y Zhou; Rhine R Shen; Eejung Kim; Ying J Lock; Ming Xu; Zhijian J Chen; William C Hahn
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

10.  Structure and ubiquitination-dependent activation of TANK-binding kinase 1.

Authors:  Daqi Tu; Zehua Zhu; Alicia Y Zhou; Cai-hong Yun; Kyung-Eun Lee; Angela V Toms; Yiqun Li; Gavin P Dunn; Edmond Chan; Tran Thai; Shenghong Yang; Scott B Ficarro; Jarrod A Marto; Hyesung Jeon; William C Hahn; David A Barbie; Michael J Eck
Journal:  Cell Rep       Date:  2013-02-28       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.